Ayala PharmaceuticalsInc Probability of Future Stock Price Finishing Over 0.0

Ayala PharmaceuticalsI's future price is the expected price of Ayala PharmaceuticalsI instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Ayala PharmaceuticalsInc performance during a given time horizon utilizing its historical volatility. Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis.
  
Please specify Ayala PharmaceuticalsI's target price for which you would like Ayala PharmaceuticalsI odds to be computed.

Ayala PharmaceuticalsI Target Price Odds to finish over 0.0

The tendency of Ayala Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 0.00 90 days 0.00 
close to 99
Based on a normal probability distribution, the odds of Ayala PharmaceuticalsI to move above the current price in 90 days from now is close to 99 (This Ayala PharmaceuticalsInc probability density function shows the probability of Ayala Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Ayala PharmaceuticalsInc has a beta of -1.3. This suggests as returns on its benchmark rise, returns on holding Ayala PharmaceuticalsInc are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, Ayala PharmaceuticalsI is expected to outperform its benchmark. Additionally Ayala PharmaceuticalsInc has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
   Ayala PharmaceuticalsI Price Density   
       Price  

Predictive Modules for Ayala PharmaceuticalsI

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Ayala PharmaceuticalsInc. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Ayala PharmaceuticalsI's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.000.000.00
Details
Intrinsic
Valuation
LowRealHigh
0.000.000.00
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Ayala PharmaceuticalsI. Your research has to be compared to or analyzed against Ayala PharmaceuticalsI's peers to derive any actionable benefits. When done correctly, Ayala PharmaceuticalsI's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Ayala PharmaceuticalsInc.

Ayala PharmaceuticalsI Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Ayala PharmaceuticalsI is not an exception. The market had few large corrections towards the Ayala PharmaceuticalsI's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Ayala PharmaceuticalsInc, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Ayala PharmaceuticalsI within the framework of very fundamental risk indicators.
α
Alpha over NYSE Composite
-0.27
β
Beta against NYSE Composite-1.3
σ
Overall volatility
0.16
Ir
Information ratio -0.07

Ayala PharmaceuticalsI Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Ayala PharmaceuticalsI for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Ayala PharmaceuticalsInc can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Ayala PharmaceuticalsI is not yet fully synchronised with the market data
Ayala PharmaceuticalsI has some characteristics of a very speculative penny stock
Ayala PharmaceuticalsI has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 3.51 M. Net Loss for the year was (40.25 M) with profit before overhead, payroll, taxes, and interest of 1.05 M.
Ayala PharmaceuticalsInc currently holds about 20.06 M in cash with (38.36 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.41.
Roughly 30.0% of the company shares are held by company insiders

Ayala PharmaceuticalsI Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Ayala Stock often depends not only on the future outlook of the current and potential Ayala PharmaceuticalsI's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Ayala PharmaceuticalsI's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding9.9 M
Cash And Short Term Investments37 M

Ayala PharmaceuticalsI Technical Analysis

Ayala PharmaceuticalsI's future price can be derived by breaking down and analyzing its technical indicators over time. Ayala Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Ayala PharmaceuticalsInc. In general, you should focus on analyzing Ayala Stock price patterns and their correlations with different microeconomic environments and drivers.

Ayala PharmaceuticalsI Predictive Forecast Models

Ayala PharmaceuticalsI's time-series forecasting models is one of many Ayala PharmaceuticalsI's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Ayala PharmaceuticalsI's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Ayala PharmaceuticalsInc

Checking the ongoing alerts about Ayala PharmaceuticalsI for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Ayala PharmaceuticalsInc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Ayala PharmaceuticalsI is not yet fully synchronised with the market data
Ayala PharmaceuticalsI has some characteristics of a very speculative penny stock
Ayala PharmaceuticalsI has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 3.51 M. Net Loss for the year was (40.25 M) with profit before overhead, payroll, taxes, and interest of 1.05 M.
Ayala PharmaceuticalsInc currently holds about 20.06 M in cash with (38.36 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.41.
Roughly 30.0% of the company shares are held by company insiders
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis.
You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

Other Consideration for investing in Ayala Stock

If you are still planning to invest in Ayala PharmaceuticalsInc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Ayala PharmaceuticalsI's history and understand the potential risks before investing.
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Commodity Directory
Find actively traded commodities issued by global exchanges
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Stocks Directory
Find actively traded stocks across global markets
Fundamental Analysis
View fundamental data based on most recent published financial statements
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Technical Analysis
Check basic technical indicators and analysis based on most latest market data